应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02179 瑞科生物-B
未开盘 12-11 16:08:09
10.000
+0.010
+0.10%
最高
10.020
最低
9.950
成交量
1.10万
今开
10.000
昨收
9.990
日振幅
0.70%
总市值
48.30亿
流通市值
31.61亿
总股本
4.83亿
成交额
11.00万
换手率
0.00%
流通股本
3.16亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
智通港股沽空统计|11月9日
智通财经网 · 11-09
智通港股沽空统计|11月9日
智通港股沽空统计|10月31日
智通财经 · 10-31
智通港股沽空统计|10月31日
距离商业化还有2年,瑞科生物-B(02179)却已掉入流动性陷阱
智通财经 · 10-26
距离商业化还有2年,瑞科生物-B(02179)却已掉入流动性陷阱
智通港股沽空统计|10月18日
智通财经 · 10-18
智通港股沽空统计|10月18日
智通港股沽空统计|10月13日
智通财经网 · 10-13
智通港股沽空统计|10月13日
瑞科生物与津巴布韦国家生物技术管理局及国际遗传工程和生物技术中心中国区域研究中心签订战略合作协议
美通社 · 10-10
瑞科生物与津巴布韦国家生物技术管理局及国际遗传工程和生物技术中心中国区域研究中心签订战略合作协议
港股异动 | 瑞科生物-B(02179)涨近6% 与易康生物签署呼吸道合胞病毒(RSV)疫苗开发合作协议
智通财经网 · 09-26
港股异动 | 瑞科生物-B(02179)涨近6% 与易康生物签署呼吸道合胞病毒(RSV)疫苗开发合作协议
瑞科生物发布2023中期业绩报告及最新进展
美通社 · 08-28
瑞科生物发布2023中期业绩报告及最新进展
瑞科生物-B(02179)发布中期业绩,股东应占亏损2.73亿元 同比减少22.06%
智通财经网 · 08-25
瑞科生物-B(02179)发布中期业绩,股东应占亏损2.73亿元 同比减少22.06%
新佐剂重组带状疱疹疫苗REC610中国临床试验申请获得受理及海外临床进展
美通社 · 07-27
新佐剂重组带状疱疹疫苗REC610中国临床试验申请获得受理及海外临床进展
瑞科生物-B(02179.HK):新佐剂重组带状疱疹疫苗REC610中国临床试验申请获得受理
格隆汇资讯 · 07-26
瑞科生物-B(02179.HK):新佐剂重组带状疱疹疫苗REC610中国临床试验申请获得受理
加载更多
公司概况
公司名称:
瑞科生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。该公司拥有一系列临床和临床前阶段的疫苗,人乳头瘤病毒(HPV)疫苗管线包括重组HPV九价候选疫苗REC603,重组HPV二价候选疫苗REC601及REC602,重组HPV四价疫苗REC604a以及重组HPV九价疫苗REC604b。该公司还参与新冠病毒疫苗的研发。该公司主要在国内市场销售其产品。
发行价格:
--
{"stockData":{"symbol":"02179","market":"HK","secType":"STK","nameCN":"瑞科生物-B","latestPrice":10,"timestamp":1702282089014,"preClose":9.99,"halted":0,"volume":11000,"delay":0,"floatShares":316138689,"shares":482963000,"eps":-1.6536976,"marketStatus":"未开盘","marketStatusCode":0,"change":0.01,"latestTime":"12-11 16:08:09","open":10,"high":10.02,"low":9.95,"amount":109955,"amplitude":0.007007,"askPrice":0,"askSize":0,"bidPrice":10.3,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-1.4514685017054454,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1702344600000},"adr":0,"listingDate":1648656000000,"adjPreClose":9.99,"volumeRatio":0.40740740650205765,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02179","defaultTab":"news","newsList":[{"id":"2382258094","title":"智通港股沽空统计|11月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2382258094","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2382258094?lang=zh_cn&edition=full","pubTime":"2023-11-09 08:20","pubTimestamp":1699489214,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,华润啤酒-R、长城汽车-R、小米集团-WR上一交易日沽空比率位于前三位,分别为100.00%、89.84%、83.21%。中国平安、小米集团-W、腾讯控股的沽空金额位居前三,分别为6.07 亿元、5.50 亿元、4.47 亿元。浙江沪杭甬、长飞光纤光缆、舜宇光学科技的偏离值位居前三,分别为39.44%、30.03%、27.21%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1021894.html","is_publish_highlight":false},{"id":"2379882557","title":"智通港股沽空统计|10月31日","url":"https://stock-news.laohu8.com/highlight/detail?id=2379882557","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2379882557?lang=zh_cn&edition=full","pubTime":"2023-10-31 08:20","pubTimestamp":1698711620,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,瑞科生物-B、华润啤酒-R、友邦保险-R上一交易日沽空比率位于前三位,分别为100.00%、100.00%、100.00%。小米集团-W、汇丰控股、腾讯控股的沽空金额位居前三,分别为6.60 亿元、5.51 亿元、5.33 亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1017663.html","is_publish_highlight":false},{"id":"2378839363","title":"距离商业化还有2年,瑞科生物-B(02179)却已掉入流动性陷阱","url":"https://stock-news.laohu8.com/highlight/detail?id=2378839363","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2378839363?lang=zh_cn&edition=full","pubTime":"2023-10-26 18:03","pubTimestamp":1698314615,"startTime":"0","endTime":"0","summary":"今年7月26日,瑞科生物-B宣布,重组带状疱疹疫苗REC610临床试验申请获得受理。5月22日,瑞科生物盘中股价一度跌至11.88港元,较上一交易日收盘价暴跌15.14%,最终收跌价为11.92港元。从成交量来看,瑞科生物流动性匮乏现象已经非常严重。从现金流情况来看,2022年,瑞科生物经营活动现金流净流出5.79亿元;当期公司现金及现金等价物为11.69亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1012832.html","is_publish_highlight":false},{"id":"2376454383","title":"智通港股沽空统计|10月18日","url":"https://stock-news.laohu8.com/highlight/detail?id=2376454383","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2376454383?lang=zh_cn&edition=full","pubTime":"2023-10-18 08:20","pubTimestamp":1697588416,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,比亚迪股份-R、安踏体育-R、京东健康-R上一交易日沽空比率位于前三位,分别为100.00%、100.00%、100.00%。建设银行、友邦保险、工商银行的沽空金额位居前三,分别为4.20 亿元、3.95 亿元、3.73 亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1007566.html","is_publish_highlight":false},{"id":"2375412968","title":"智通港股沽空统计|10月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2375412968","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2375412968?lang=zh_cn&edition=full","pubTime":"2023-10-13 08:20","pubTimestamp":1697156432,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,新鸿基地产-R、小米集团-WR、快手-WR上一交易日沽空比率位于前三位,分别为86.63%、81.62%、77.21%。建设银行、工商银行、友邦保险的沽空金额位居前三,分别为10.00 亿元、8.76 亿元、6.64 亿元。新高教集团、瑞安房地产、中集集团的偏离值位居前三,分别为45.45%、40.16%、35.42%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1005547.html","is_publish_highlight":false},{"id":"2374579508","title":"瑞科生物与津巴布韦国家生物技术管理局及国际遗传工程和生物技术中心中国区域研究中心签订战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2374579508","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2374579508?lang=zh_cn&edition=full","pubTime":"2023-10-10 13:08","pubTimestamp":1696914480,"startTime":"0","endTime":"0","summary":"泰州2023年10月10日 /美通社/ -- 2023年10月8日,津巴布韦国家生物技术管理局CEO萨瓦迪博士及国际遗传工程和生物技术中心中国区域研究中心杨义力博士一行到访瑞科生物,在前期多轮洽谈的基础上,萨瓦迪博士一行对瑞科生物新冠/带状疱疹疫苗及HPV疫苗生产设施进行了实地考察。在泰州医药高新技术产业园区领导的见证下,三方共同签署战略合作协议。瑞科生物将积极践行国家\"一带一路\"倡议,抢抓疫苗海外市场布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4233745_ZH33745_1","is_publish_highlight":false},{"id":"2370210796","title":"港股异动 | 瑞科生物-B(02179)涨近6% 与易康生物签署呼吸道合胞病毒(RSV)疫苗开发合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2370210796","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2370210796?lang=zh_cn&edition=full","pubTime":"2023-09-26 09:59","pubTimestamp":1695693583,"startTime":"0","endTime":"0","summary":"瑞科生物-B(02179)涨超5%,截至发稿,涨5.96%,报12.8港元,成交额451.54万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20230926/20230926100029_37026.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20230926/20230926100029_37026.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/999578.html","is_publish_highlight":false},{"id":"2362119936","title":"瑞科生物发布2023中期业绩报告及最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2362119936","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2362119936?lang=zh_cn&edition=full","pubTime":"2023-08-28 10:28","pubTimestamp":1693189680,"startTime":"0","endTime":"0","summary":"泰州2023年8月28日 /美通社/ -- 创新型疫苗公司瑞科生物发布2023年中期业绩报告及最新进展。带状疱疹尚无特效药,接种疫苗是预防带状疱疹的有效手段。2023年3月,ReCOV获得蒙古国紧急使用授权。2023年4月,公司定向发行内资股获中国证监会批复。该批复自同意注册之日起12个月内有效。财务摘要 现金及银行结余 截至2023年6月30日,现金和现金等价物约为人民币10.99亿元,而截至2022年12月31日为人民币13.25亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4193885_ZH93885_1","is_publish_highlight":false},{"id":"2362732409","title":"瑞科生物-B(02179)发布中期业绩,股东应占亏损2.73亿元 同比减少22.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2362732409","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2362732409?lang=zh_cn&edition=full","pubTime":"2023-08-25 21:22","pubTimestamp":1692969762,"startTime":"0","endTime":"0","summary":"瑞科生物-B(02179)发布截至2023年6月30日止6个月中期业绩,该集团取得...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_6.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_6.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/983421.html","is_publish_highlight":false},{"id":"2354565202","title":"新佐剂重组带状疱疹疫苗REC610中国临床试验申请获得受理及海外临床进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2354565202","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2354565202?lang=zh_cn&edition=full","pubTime":"2023-07-27 10:32","pubTimestamp":1690425120,"startTime":"0","endTime":"0","summary":"泰州2023年7月27日 /美通社/ --瑞科生物欣然宣布,已于近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组带状疱疹疫苗REC610临床试验申请。据估计,我国50岁及以上人群每年新发带状疱疹病例在150万例以上。核心产品重组HPV九价疫苗REC603,临床进度领先。新佐剂重组带状疱疹疫苗REC610具有较好的免疫原性,其表现非劣于国际主流的Shingrix疫苗,目前已进入临床阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4168267_ZH68267_1","is_publish_highlight":false},{"id":"2354585706","title":"瑞科生物-B(02179.HK):新佐剂重组带状疱疹疫苗REC610中国临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2354585706","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2354585706?lang=zh_cn&edition=full","pubTime":"2023-07-26 21:03","pubTimestamp":1690376607,"startTime":"0","endTime":"0","summary":"格隆汇7月26日丨瑞科生物-B公告,集团已于近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组带状疱疹疫苗REC610临床试验申请。此前,公司已于2023年2月在菲律宾开展以葛兰素史克Shingrix为阳性对照的REC610首次人体试验。目前该研究进展顺利,所有受试者已完成两剂疫苗接种后30天随访,且安全性与耐受性良好。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230726210502825312a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230726210502825312a8&s=b","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":-0.1379},{"period":"3month","weight":-0.0741},{"period":"6month","weight":-0.2806},{"period":"1year","weight":-0.5465},{"period":"ytd","weight":-0.5935}],"compareEarnings":[{"period":"1week","weight":-0.0267},{"period":"1month","weight":-0.0582},{"period":"3month","weight":-0.1012},{"period":"6month","weight":-0.1652},{"period":"1year","weight":-0.1859},{"period":"ytd","weight":-0.181}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。该公司拥有一系列临床和临床前阶段的疫苗,人乳头瘤病毒(HPV)疫苗管线包括重组HPV九价候选疫苗REC603,重组HPV二价候选疫苗REC601及REC602,重组HPV四价疫苗REC604a以及重组HPV九价疫苗REC604b。该公司还参与新冠病毒疫苗的研发。该公司主要在国内市场销售其产品。","exchange":"SEHK","name":"瑞科生物-B","nameEN":"RECBIO-B"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.19.1","shortVersion":"4.19.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞科生物-B(02179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞科生物-B,02179,瑞科生物-B股票,瑞科生物-B股票老虎,瑞科生物-B股票老虎国际,瑞科生物-B行情,瑞科生物-B股票行情,瑞科生物-B股价,瑞科生物-B股市,瑞科生物-B股票价格,瑞科生物-B股票交易,瑞科生物-B股票购买,瑞科生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞科生物-B(02179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}